Literature DB >> 21835150

The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.

Avi Fischer1, Kevin T Ousdigian, James W Johnson, Jeffrey M Gillberg, Bruce L Wilkoff.   

Abstract

BACKGROUND: The relationship between shocks, device programming, and atrial fibrillation (AF) with a rapid ventricular rate (AF + RVR) using continuous daily monitoring has not been studied in large number of patients with implantable cardioverter-defibrillators (ICDs).
OBJECTIVE: The aim of this analysis was to determine the impact of ICD programming and ventricular rate control during AF on ICD shocks.
METHODS: An observational cohort analysis was performed with dual-chamber ICD and cardiac resynchronization therapy-defibrillator devices. The primary endpoint was spontaneous all-cause shocked episodes per 100 patient-years. Shock reduction programming strategies were entered into a multivariable model including slowest ventricular tachycardia/ventricular fibrillation (VT/VF) detection threshold, number of intervals to detect VF (NID), supraventricular tachycardia (SVT) discriminators ON, antitachycardia pacing (ATP) ON for fast VTs (FVTs) and AF + RVR (AF ≥1 hour for ≥1 day with average ≥110 beats per minute). We also characterized the predictive ability of AF + RVR to identify patients at risk of subsequent shocks.
RESULTS: There were 106,513 patients at 2858 institutions, with 2.5 ± 1.4 years of follow-up, 75% being male, age 67 ± 12 years, 59% with dual-chamber ICDs, and 11% with AF + RVR. A total of 22,062 patients (21%) received 82,396 shocks. After adjusting for all variables, AF + RVR, slower VT/VF detection threshold, and shorter VF NID were found to be associated with more shocks (P < .05 for all). Continuous monitoring of AF + RVR identified patients at up to 5-fold increased risk of shocks.
CONCLUSIONS: Faster VT/VF detection thresholds, longer detection durations, use of SVT discriminators, and delivery of ATP reduces all-cause ICD shocks. Continuous monitoring of AF + RVR identifies patients at the highest risk of future ICD shocks.
Copyright © 2012 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835150     DOI: 10.1016/j.hrthm.2011.08.005

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  10 in total

Review 1.  Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.

Authors:  Shantanu Sarkar; Paul D Ziegler
Journal:  J Atr Fibrillation       Date:  2013-06-30

2.  Single-brand dual-chamber discriminators to prevent inappropriate shocks in patients implanted with prophylactic implantable cardioverter defibrillators: a propensity-weighted comparison of single- and dual-chamber devices.

Authors:  Sem Briongos-Figuero; Ana Sánchez; M Luisa Pérez; José B Martínez-Ferrer; Enrique García; Xavier Viñolas; Ángel Arenal; Javier Alzueta; Nuria Basterra; Aníbal Rodríguez; Ignacio Lozano; Roberto Muñoz-Aguilera
Journal:  J Interv Card Electrophysiol       Date:  2018-12-06       Impact factor: 1.900

3.  Effects of smoking in patients treated with cardiac resynchronization therapy.

Authors:  Laura Perrotta; Brunilda Xhaferi; Marco Chiostri; Paolo Pieragnoli; Giuseppe Ricciardi; Luigi Di Biase; Andrea Natale; Ilaria Ricceri; Mazda Biria; Dhanunjay Lakkireddy; Alessandro Valleggi; Michele Emdin; Federica Michelotti; Giosuè Mascioli; Angela Pandozi; Massimo Santini; Luigi Padeletti
Journal:  Intern Emerg Med       Date:  2012-12-19       Impact factor: 3.397

4.  Impact of the introduction of a standardised ICD programming protocol: real-world data from a single centre.

Authors:  Nicholas Sunderland; Amit Kaura; Anthony Li; Ravi Kamdar; Ed Petzer; Para Dhillon; Francis Murgatroyd; Paul A Scott
Journal:  J Interv Card Electrophysiol       Date:  2016-06-03       Impact factor: 1.900

Review 5.  Cardiac Resynchronization in Patients with Atrial Fibrillation.

Authors:  S Serge Barold; Bengt Herweg
Journal:  J Atr Fibrillation       Date:  2015-12-31

6.  Relevance of Monitoring Atrial Fibrillation in Clinical Practice.

Authors:  Thorsten Lewalter; Giuseppe Boriani
Journal:  Arrhythm Electrophysiol Rev       Date:  2012-09

Review 7.  Programming implantable cardioverter/defibrillators and outcomes.

Authors:  Fritz W Horlbeck; Joerg O Schwab
Journal:  F1000Prime Rep       Date:  2015-01-05

8.  2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Authors:  Bruce L Wilkoff; Laurent Fauchier; Martin K Stiles; Carlos A Morillo; Sana M Al-Khatib; Jesœs Almendral; Luis Aguinaga; Ronald D Berger; Alejandro Cuesta; James P Daubert; Sergio Dubner; Kenneth A Ellenbogen; N A Mark Estes; Guilherme Fenelon; Fermin C Garcia; Maurizio Gasparini; David E Haines; Jeff S Healey; Jodie L Hurtwitz; Roberto Keegan; Christof Kolb; Karl-Heinz Kuck; Germanas Marinskis; Martino Martinelli; Mark McGuire; Luis G Molina; Ken Okumura; Alessandro Proclemer; Andrea M Russo; Jagmeet P Singh; Charles D Swerdlow; Wee Siong Teo; William Uribe; Sami Viskin; Chun-Chieh Wang; Shu Zhang
Journal:  J Arrhythm       Date:  2016-02-01

9.  Atrial fibrillation in cardiac resynchronization therapy.

Authors:  Mark K Elliott; Vishal S Mehta; Dejana Martic; Baldeep S Sidhu; Steven Niederer; Christopher A Rinaldi
Journal:  Heart Rhythm O2       Date:  2021-12-17

10.  Inappropriate shocks from a transvenous implantable defibrillator caused by atrial fibrillation and a missed atrial septal defect in a patient with a modified Bentall procedure.

Authors:  Anna Kostopoulou; Epameinontas Fountas; Olga Karapanagiotou; Stamatis Kyrzopoulos
Journal:  Eur Heart J Case Rep       Date:  2021-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.